Liver Transplantation for Hepatitis B in Early Adulthood: Analysis of the United Network for Organ Sharing Database

G Rifai1, A Anani2, I A Hanouneh1

  • 1Department of Pediatric Gastroenterology, The Cleveland Clinic, Cleveland, Ohio.

Transplantation Proceedings
|December 10, 2016
PubMed

Insights

Liver transplantation (LT) for young adults with chronic hepatitis B virus (HBV) infection shows poor survival rates, highlighting the need for earlier intervention. Outcomes improved after the implementation of Model for End-stage Liver Disease (MELD) prioritization.

Area of Science:

  • Hepatology
  • Transplantation Medicine
  • Virology

Background:

  • Chronic hepatitis B virus (HBV) infection typically has a mild course in children, potentially delaying treatment.
  • A subset of patients experience rapid progression to cirrhosis, necessitating liver transplantation (LT) in early adulthood.
  • Assessing outcomes in young adults undergoing LT for HBV is crucial for improving patient care.

Purpose of the Study:

  • To characterize HBV-positive young adults who underwent LT.
  • To evaluate post-transplant patient and graft survival.
  • To compare outcomes between the pre- and post-Model for End-stage Liver Disease (MELD) prioritization eras.

Main Methods:

  • Retrospective analysis of the United Network for Organ Sharing (UNOS) database (1987-2012).
  • Inclusion of young adult patients (18-35 years) with HBV as the primary diagnosis or HBsAg positivity at LT.
  • Kaplan-Meier analysis for survival and Cox regression for associated factors.

Main Results:

  • 522 HBV-infected subjects underwent LT; average age was 28.4 years.
  • Graft failure and infection were leading causes of death; only 58% survived with their first LT.
  • Post-MELD era showed higher 5-year patient and graft survival rates compared to the pre-MELD era.

Conclusions:

  • Liver transplantation for HBV in young adults is associated with poor outcomes and premature mortality.
  • Findings suggest a need for more aggressive HBV evaluation and treatment in pediatric patients.
  • Improved outcomes in the post-MELD era may stem from better pre-transplant management and HBV treatments.
Abstract